DEFA14A: Immix Biopharma Sets Date for Annual Stockholders Meeting, Outlines Key Proposals

Immix Biopharma announces its annual stockholders meeting to be held on June 20, 2025, featuring the election of eight directors and ratification of its accounting firm.

Summary

• Immix Biopharma, Inc. will hold its Annual Meeting of Stockholders on June 20, 2025, at 12:00 p.m. EDT at the company's office in Los Angeles.
• The meeting will address the election of eight directors and the ratification of Crowe LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
• The Board of Directors recommends a vote FOR all director nominees and FOR the ratification of Crowe LLP.
• Stockholders can access proxy materials online or request them by e-mail or first-class mail.
• Voting can be done online, by mail, or in person.
• Requests for paper copies of the proxy materials must be made on or before June 8, 2025, to ensure timely delivery.

Sentiment

Score: 7

Explanation: The document is a routine announcement of an upcoming shareholder meeting, with clear and straightforward information. The sentiment is neutral to positive as it facilitates shareholder participation.

Positives

• Stockholders have multiple convenient options for accessing proxy materials and casting their votes.
• The board clearly communicates its recommendations on the key proposals.

Future Outlook

The document outlines the matters to be addressed at the upcoming annual meeting, focusing on governance and financial oversight.

Management Comments

• Ilya Rachman, Chairman and Chief Executive Officer, signed the notice on behalf of the Board of Directors.

Industry Context

This announcement is a standard part of corporate governance, ensuring shareholders have the opportunity to participate in key decisions regarding the company's direction and oversight.

Stakeholder Impact

• Shareholders are encouraged to participate in the voting process to influence the election of directors and the selection of the company's accounting firm.

Next Steps

• Stockholders should review the proxy materials and vote on the proposals.
• The company will hold its Annual Meeting of Stockholders on June 20, 2025.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, Directors, Accounting Firm, Immix Biopharma, Voting